Eczema cream recalled over risk of ‘life-threatening’ staph infection

The Food and Drug Administration (FDA) issued a nationwide recall for a specific over-the-counter eczema cream due to potential contamination with Staphylococcus aureus (staph) bacteria.

If you or someone you know uses eczema treatments, check your medicine cabinets for the following specific product details:

Recalled Product Details

  • Brand Name: MG217 Multi-symptom Treatment Cream & Skin Protectant Eczema Cream
  • Size: 6-oz. tubes
  • Manufacturer: Pharmacal
  • Lot Number: 1024088
  • Expiration Date: November 2026
  • Product Code / UPC: 5106 / 012277051067
  • Distribution: Sold nationwide at various retail stores and online via Amazon.

The Risk

Applying a product contaminated with Staphylococcus aureus directly to compromised skin (like an eczema flare-up) significantly increases the risk of infection.

While no injuries or adverse reactions have been reported at the time of the recall notice, the FDA warns that the bacteria can lead to a range of complications. Individuals with weakened immune systems or open skin barriers are at the highest risk for:

  • Severe skin infections
  • Bone and joint infections
  • Bloodstream infections
  • Life-threatening conditions like sepsis and septic shock

What You Should Do

  1. Stop Using It: If your tube matches the lot number above, stop using it immediately and throw it away or prepare it for a return.
  2. Contact the Manufacturer: You can reach Pharmacal for return info or questions at 800-558-6614 or via email at [email protected] (Monday–Friday, 8 a.m. to 5 p.m. CT).
  3. Monitor Your Skin: If you have used this specific lot and notice signs of an worsening infection (increased redness, swelling, pus, or fever), contact a healthcare provider right away.
(Visited 17 times, 1 visits today)